Veno-Arterial Extracorporeal Membrane Oxygenation for Treating Refractory Shock in Severe Metformin-Associated Lactic Acidosis: A Case Report
- PMID: 40291305
- PMCID: PMC12022155
- DOI: 10.7759/cureus.81197
Veno-Arterial Extracorporeal Membrane Oxygenation for Treating Refractory Shock in Severe Metformin-Associated Lactic Acidosis: A Case Report
Abstract
Metformin-associated lactic acidosis (MALA) is a rare but life-threatening complication with mortality rates exceeding 10-30%. While renal replacement therapy (RRT) remains the cornerstone of treatment, mechanical circulatory support may be necessary in cases complicated by severe cardiovascular dysfunction. We report a case of severe MALA with unprecedented metabolic derangement successfully treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and continuous renal replacement therapy (CRRT). A 39-year-old male with type 2 diabetes mellitus presented with altered mental status following influenza A infection. Initial assessment revealed severe metabolic acidosis (pH 6.355) with markedly elevated lactate (52.7 mmol/L), acute kidney injury, and cardiovascular collapse. Echocardiography demonstrated severe left ventricular dysfunction with an ejection fraction below 20%. Despite initial resuscitation efforts, including high-dose vasopressors, the patient developed cardiac arrest with pulseless electrical activity, requiring cardiopulmonary resuscitation. After the return of spontaneous circulation, VA-ECMO was initiated for refractory shock unresponsive to high-dose vasopressors. MALA was diagnosed based on the clinical presentation and medication history, although metformin levels could not be measured due to assay unavailability. Under combined VA-ECMO and CRRT support, the patient's metabolic parameters improved steadily, with a gradual decrease in lactate levels and an improvement in pH. Left ventricular function recovered significantly, allowing VA-ECMO discontinuation after 26 hours. The patient was successfully weaned from mechanical ventilation with subsequent rehabilitation, achieving discharge with intact cognitive function and no neurological sequelae. By this time, both cardiac and renal functions had normalized. This case demonstrates the successful use of mechanical circulatory support in extreme metabolic derangement and illustrates how viral illnesses can precipitate severe MALA through acute kidney injury. The successful outcome suggests that early recognition and aggressive intervention with combined VA-ECMO and CRRT might be beneficial in selected patients with MALA-induced cardiovascular collapse. This case also highlights the importance of considering MALA in unexplained severe lactic acidosis, particularly in diabetic patients during acute illness.
Keywords: continuous renal replacement therapy (crrt); metformin-associated lactic acidosis; refractory shock; severe acidemia; veno-arterial extracorporeal membrane oxygenation (va ecmo).
Copyright © 2025, Sai et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: A case report.Medicine (Baltimore). 2020 Jun 26;99(26):e20990. doi: 10.1097/MD.0000000000020990. Medicine (Baltimore). 2020. PMID: 32590812 Free PMC article.
-
Life-Threatening Metformin-Induced Lactic Acidosis Associated With Euglycemic Ketoacidosis and Acute Multiorgan Dysfunction: A Case Report.Cureus. 2025 Apr 21;17(4):e82717. doi: 10.7759/cureus.82717. eCollection 2025 Apr. Cureus. 2025. PMID: 40400858 Free PMC article.
-
Mortality and renal prognosis in isolated metformin-associated lactic acidosis treated with continuous renal replacement therapy and citrate-calcium-anticoagulation.Acta Anaesthesiol Scand. 2020 Oct;64(9):1305-1311. doi: 10.1111/aas.13659. Epub 2020 Jul 7. Acta Anaesthesiol Scand. 2020. PMID: 32564362
-
Extracorporeal membrane oxygenation in the treatment of poisoned patients.Clin Toxicol (Phila). 2013 Jun;51(5):385-93. doi: 10.3109/15563650.2013.800876. Epub 2013 May 23. Clin Toxicol (Phila). 2013. PMID: 23697460 Review.
-
Metformin associated lactic acidosis (MALA): clinical profiling and management.J Nephrol. 2016 Dec;29(6):783-789. doi: 10.1007/s40620-016-0267-8. Epub 2016 Jan 22. J Nephrol. 2016. PMID: 26800971 Review.
References
-
- Incidence of lactic acidosis in metformin users. Stang M, Wysowski DK, Butler-Jones D. Diabetes Care. 1999;22:925–927. - PubMed
Publication types
LinkOut - more resources
Full Text Sources